Pregnancy and flying: ICRP and ACOG guidance compared

One of the most common questions sent to hello@flightradiation.com is the same question pregnant women have been asking obstetricians and aircrew schedulers for decades: is flying during pregnancy a radiation problem? The answer requires distinguishing two reference numbers that are often conflated in the popular press but that come from different bodies and serve different purposes. This guide pulls them apart, sources each, and shows how to map them to typical and atypical flying patterns. Throughout, we emphasise that none of this is medical advice — the right person to discuss pregnancy radiation risk with is your obstetrician, and for crew, your employer's radiation-safety officer.

The ICRP-103 number: 1 mSv across the remainder of declared pregnancy

ICRP Publication 103 §5.4.2 states that, once an occupationally-exposed worker has declared her pregnancy, the conceptus should be afforded broadly the same level of protection as a member of the public — and that this is achieved by limiting the additional equivalent dose to the conceptus to approximately 1 mSv across the remainder of pregnancy ^[1]. This is an occupational protection limit, not a clinical threshold of harm. It exists to ensure that pregnant radiation workers' work practices do not raise the fetus's dose above the level we accept for the public.

ICRP Publication 132 (2016) reiterates this 1 mSv figure specifically for the aircrew context and recommends operators implement work-pattern modifications (reduced flying hours, lower-latitude assignments, ground duty) for crew members who declare pregnancy ^[2]. The ICRP wording is careful: the 1 mSv is a protection target, not the boundary of harm.

The ACOG number: 50 mGy as the lower bound of demonstrated risk

The American College of Obstetricians and Gynecologists' Committee Opinion 656 (issued 2016 and reaffirmed since) reviews the obstetric and epidemiological evidence on diagnostic imaging during pregnancy. It states that "fetal exposure to less than 5 rad (50 mGy) has not been associated with an increase in fetal anomalies or pregnancy loss" ^[3]. This is a clinical-risk statement based on multiple cohorts and on the underlying radiobiology of stochastic vs deterministic effects.

50 mGy is fifty times the ICRP occupational protection target of 1 mSv. The numbers are not in conflict — they are answering different questions:

• ICRP-103 1 mSv: what dose-reduction work practices should be implemented for a pregnant radiation worker.
• ACOG 656 50 mGy: at what cumulative fetal dose do we have evidence of increased risk of anomalies or pregnancy loss.

It is reasonable to use the ICRP figure as an operational target and the ACOG figure as the threshold below which clinical worry is not warranted by the evidence. We do that in the FlightRadiation report.

What flying actually adds to fetal dose

Fetal dose from flying is essentially the same as the maternal effective dose at cruise altitude. The conceptus is surrounded by maternal tissue but cosmic-ray secondaries (especially neutrons and the electromagnetic cascade) are penetrating enough that the dose differential between mother and fetus is small. ICRP-132 treats fetal dose from cosmic radiation as equal to the maternal effective dose for protection purposes ^[2].

Per-segment doses for typical commercial flights:

Route	Approx fetal dose, single one-way segment (mSv)
Short-haul domestic US (e.g. LAX–PHX, FL340, 1.5 hr)	0.005–0.010
Transcontinental US (e.g. JFK–SFO, FL380, 6 hr)	0.025–0.040
Transatlantic (e.g. JFK–LHR, FL370, 7 hr)	0.040–0.060
Polar transpolar (e.g. JFK–HKG, FL390, 15 hr)	0.090–0.130

These are CARI-7A-derived figures for the 2026 solar-cycle phase ^[4].

Mapping the numbers to flying patterns

Three illustrative patterns, with fetal dose accumulated across pregnancy (assumed 40 weeks of exposure window):

Pattern	Annual flying volume	Approx fetal dose accumulated over pregnancy (mSv)	Where this sits vs limits
Occasional flier — two transatlantic round-trips during pregnancy	~ 0.2 mSv extra dose	0.20–0.25	Far below ICRP-103 1 mSv; trivially below ACOG 50 mGy.
Frequent business flier — biweekly transatlantic for the first 28 weeks	~ 14 segments	0.6–0.8	Approaching the ICRP-103 1 mSv target; well below ACOG 50 mGy.
Long-haul cabin crew flying 60 hours/month, mixed long-haul	~ 480 flight hours	2.0–3.0	Exceeds ICRP-103 1 mSv; ~ 4–6% of ACOG 50 mGy.

For the first pattern — and this captures almost all pregnant passengers — neither the ICRP-103 protection target nor the ACOG clinical evidence threshold is approached.

For the second pattern — frequent business travel — the ICRP-103 1 mSv occupational protection target may be approached or exceeded. This is not a clinical-harm threshold (the evidence behind ACOG 656 still applies), but it is the figure ICRP recommends as the working ceiling for occupational fetal protection. A conversation with an obstetrician and, if applicable, an employer-provided occupational-medicine review is appropriate.

For the third pattern — long-haul cabin crew — the ICRP-103 figure is exceeded for typical flying patterns, and this is exactly the situation ICRP-132 contemplates: operators are recommended to modify work patterns for pregnant crew. In EURATOM-regulated EU member states, this is a regulatory obligation, not a recommendation. In the US the FAA's AC 120-61B recommends similar accommodation but it is not regulatory ^[5].

Things that are not the main concern

• Solar particle events. Large events are rare and the SPE contribution to fetal dose is small in expectation (see our SPE guide). They are not a reason to avoid flying during pregnancy.
• Airport scanners. Backscatter-X-ray and millimetre-wave scanners deliver doses that are biologically trivial relative to flight dose, and pregnant travellers can request a pat-down alternative if they prefer.
• Cabin pressure and oxygen. A separate set of concerns from radiation, and outside the scope of this site.

What we recommend you do

1. For occasional flying — the overwhelming majority of pregnant passengers — the fetal dose contribution is small relative to both ICRP and ACOG references. No special precautions are warranted on radiation grounds.
2. For frequent flying that approaches the ICRP-103 1 mSv target, run the numbers with a CARI-based tool (the free FAA CARI-7A web tool will do this segment by segment; the FlightRadiation report bundles it for an entire flying pattern). Then discuss the actual accumulated dose with your obstetrician.
3. For aircrew, your employer's radiation-safety officer is the right point of contact, and the operator's dosimetry program should already be aware of the ICRP-132 recommendations.
4. If you fly into a known major SPE window, flag the segment dates to your obstetrician — but recognise the SPE additional dose is typically a small fraction of the GCR baseline even for a major event.

Trimester sensitivity

Radiosensitivity of the conceptus is not constant across pregnancy. The first 2–4 weeks (pre-implantation period) is generally considered the all-or-nothing window: radiation effects either prevent implantation entirely or have no detectable effect on the subsequent pregnancy. From roughly week 3 through week 8 — organogenesis — the conceptus is most sensitive to teratogenic effects from radiation. From weeks 8 through 25, dose-related risks include impairment of central-nervous-system development. After week 25, the fetus shows radiosensitivity closer to the postnatal infant ^[1].

Both the ICRP-103 1 mSv figure and the ACOG 656 50 mGy figure are stated as cumulative doses across the relevant period — not per-week or per-trimester rates. For practical purposes this means a flying pattern can be evaluated on its cumulative-dose endpoint rather than on per-trimester compliance. Where flying volume is heavy and the option exists, concentrating ground duty in the most sensitive period (weeks 3–25) is the conservative choice; ICRP and the major aircrew dosimetry programs recommend this kind of work-pattern modification.

Why the ICRP figure is so much lower than the ACOG figure

The 50× ratio between the ACOG 50 mGy clinical-evidence threshold and the ICRP-103 1 mSv occupational protection target reflects deliberate conservatism in protection philosophy, not a disagreement about biology. ICRP applies its public-protection limit to the fetus once pregnancy is declared because the fetus is involuntarily exposed via the mother's occupational activity. The public limit (1 mSv/yr) is itself set well below any level at which population-level harm is detectable; the fetus is treated to the same standard. By contrast, ACOG is summarising the clinical question that obstetricians actually face — at what cumulative diagnostic-imaging dose do we have evidence of fetal anomalies — and the relevant evidence base supports 50 mGy as a conservative threshold below which excess risk is not apparent.

For a frequent flier weighing whether her pattern is "safe," the honest answer is: well below the ACOG threshold of clinical evidence (good); possibly approaching the ICRP occupational protection target (worth discussing with an obstetrician and, if employed, a radiation-safety officer). The gap between the two is not a measure of risk; it is a measure of the conservatism built into the occupational framework.

Last reviewed 30 June 2026 · See our methodology and sources.